Bayer wins Roundup weedkiller cancer trial while awaiting settlement ruling
The unanimous verdict extends Bayer’s defense of Roundup after the Supreme Court limited failure-to-warn claims and left 65,000 related cases pending.
- On Thursday, a Missouri Circuit Court jury reached a unanimous verdict favoring Monsanto in a lawsuit brought by three women alleging Roundup weedkiller caused their cancer.
- This decision marks the first trial since the U.S. Supreme Court ruled earlier this year that plaintiffs cannot argue Roundup labels failed to warn of cancer risks, as the Environmental Protection Agency requires no such warning.
- Theresa Aretino, Cynthia Fernandez, and Betty Larkin pursued claims of design defect, fraud, and negligence, alleging the weedkiller caused their non-Hodgkin lymphoma diagnoses.
- Bayer is seeking a $7.25 billion settlement regarding approximately 65,000 other pending Roundup cases while defending the product's safety worldwide.
- Despite the International Agency for Research on Cancer labeling glyphosate "probably carcinogenic" in 2015, Bayer rejects the study, citing the Environmental Protection Agency's consistent approval of Roundup as safe.
24 Articles
24 Articles
Bayer wins Roundup weedkiller cancer trial while awaiting settlement ruling
Bayer won a trial on Thursday over claims by three women that its Roundup weedkiller caused their cancer, while awaiting a broader ruling from a separate court on the company's $7.25 billion effort to settle other Roundup cases.
Bayer wins again in the glyphosate dispute. In Missouri, the plaintiffs had made other accusations than in previous proceedings - which means the verdict for the Group.
The process is the second within a few months that Bayer won in the Cause Glyphosate. A further lawsuit is pending. Bayer is facing billions.
The Independent
The Independent (US)Bayer scores major Roundup victory as thousands of cancer lawsuits loom
The trial was a test for the continued viability of Roundup lawsuits after a Supreme Court ruling in Bayer's favor limited the legal claims that plaintiffs can bring
Bayer wins first Roundup cancer trial after US Supreme Court ruling: What changes for 65,000 claimants?
Bayer won its first Roundup cancer trial since a US Supreme Court ruling restricted plaintiffs’ legal arguments. The verdict could influence around 65,000 pending claims as Bayer pursues a proposed $7.25 billion settlement.
Coverage Details
Bias Distribution
- 53% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
